U.S. C-Reactive Protein Testing Market Size & Outlook

Name: U.S. C-Reactive Protein Testing Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The c-reactive protein testing market in the United States is expected to reach a projected revenue of US$ 2,150.2 million by 2033. A compound annual growth rate of 1.5% is expected of the United States c-reactive protein testing market from 2026 to 2033.

Clinical Diagnostics
- Reagents & Assays
  - C-reactive Protein Testing Market Outlook

U.S. c-reactive protein testing assay type outlook (Revenue, USD million, 2021-2033)
- Immunoturbidimetric assay
- ELISA
  - Clinical
  - Non-Clinical
- Chemiluminescence Immunoassay (CLIA )
- Others
U.S. c-reactive protein testing detection range outlook (Revenue, USD million, 2021-2033)
- hs-CRP
- Conventional CRP
- cCRP
U.S. c-reactive protein testing disease type outlook (Revenue, USD million, 2021-2033)
- Cardiovascular Diseases
- Cancer
- Rheumatoid arthritis
- Inflammatory bowel disease
- Endometriosis
- Lupus
- Others
U.S. c-reactive protein testing end use outlook (Revenue, USD million, 2021-2033)
- Clinics
  - Physician Office
  - Small Clinic
  - Others
- Hospitals
  - Urban Setting
  - Rural Setting
- Laboratories
  - Urban Setting
  - Rural Setting
- Assisted Living Healthcare Facilities
  - Urban Setting
  - Rural Setting
- Home
- Others

U.S. C-Reactive Protein Testing Market Size & Outlook

Data Tree

Sign up - it's easy, and free!